Find clinical trials for Eczema in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Eczema trials near Durham, NC, USA:
The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis. Atopic dermatitis, also referred to as eczema...
Phase 4
Durham, North Carolina, United States and 29 other locations
This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety...
Phase 2
Raleigh, North Carolina, United States and 26 other locations
Global Assessment for Atopic Dermatitis (vIGA-AD).* Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Eczema...
Phase 3
Durham, North Carolina, United States and 196 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Cary, North Carolina, United States and 557 other locations
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Phase 3
Raleigh, North Carolina, United States and 320 other locations
The study is a multicenter clinical trial and is designed as a proof-of-concept study to evaluate the efficacy, safety, tolerability, PK, immunogenic...
Phase 2
Cary, North Carolina, United States and 16 other locations
The purpose of this trial is to test different doses of the trial medicine (LEO 138559) at treating moderate to severe atopic dermatitis in adults. T...
Phase 2
Raleigh, North Carolina, United States and 72 other locations
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subje...
Phase 3
Durham, North Carolina, United States and 244 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Phase 3
Durham, North Carolina, United States and 342 other locations
The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.
Phase 3
Raleigh, North Carolina, United States and 308 other locations
Clinical trials
Research sites
Resources
Legal